An intravenous programmed death-1 inhibitor for the first-line treatment of patients with unresectable or metastatic melanoma.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
An intravenous programmed death-1 inhibitor for the first-line treatment of patients with unresectable or metastatic melanoma.
If you have a Hayes login, click here to view the full report on the Knowledge Center.